#dc#dc comics#batman#bruce wayne#dick grayson#dc fanart#batfamily#batfam#tim drake
seen from Italy
seen from Türkiye
seen from United States
seen from United States
seen from Türkiye
seen from Germany
seen from Russia
seen from United States
seen from United Kingdom
seen from Japan
seen from Malaysia
seen from Malaysia
seen from Germany
seen from Australia
seen from Russia
seen from Brazil
seen from Malaysia
seen from China
seen from China
seen from China
Avelumab (Mechanism of Action)
Avelumab (Mechanism of Action)
In this article we will discuss Avelumab (Mechanism of Action). So, let’s get started. Avelumab is a programmed death ligandl (PD-L1) blocking antibody. Avelumab-is a human IgG1 lambda monoclonal antibody produced in Chinese hamster ovary cells and has a molecular weight of approximately 147 kDa.Avelumab (BAVENCIO®) Injection for intravenous use is a sterile, preservative-free, non-pyrogenic,…
View On WordPress
Avelumab
In this article, we will discuss about Avelumab (Dosage Overview). So, let’s get started. IndicationsMetastatic Merkel Cell CarcinomaAvelumab (BAVENCIO®) is indicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC). This indication is approved under accelerated approval based on tumor response rate and duration of response.…
View On WordPress
Top Pharma News of the Week
Top Pharma News of the Week
All The Most Important Pharmaceutical News Stories Of The Week – February 2018 – Week #3 US, EU, and Japan Health Authorities Accept Regulatory Submissions for Review of Pfizer’s Third-Generation ALK Inhibitor Lorlatinib
February 12, 2018
Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) accepted and granted Priority Review to the company’s New Drug Application for…
View On WordPress
Top Pharma News of the Week
U.S. FDA Approves Pfizer’s Bosulif® (Bosutinib) For the Treatment of Patients with Newly-Diagnosed Ph+ Chronic Myelogenous Leukemia (CML)
December 19, 2017
Pfizer Inc. has announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to expand the indication for BOSULIF® (bosutinib) to include adult patients with newly-diagnosed chronic phase…
View On WordPress
Merck KGaA, Pfizer's avelumab misses goal in gastric ca... - https://wp.me/p8XyML-cPL - #Avelumab, #Ca, #Gastric, #Goal, #KGaA, #Merck, #Misses, #Pfizers
Top Pharma News | May - June 2017
Top Pharma News | May – June 2017
AstraZeneca’s Imfinzi (durvalumab) receives US FDA accelerated approval for previously treated patients with advanced bladder cancer
01 May 2017
AstraZeneca and its global biologics research and development arm, MedImmune, have announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Imfinzi (durvalumab). Imfinzi is indicated for the treatment of patients…
View On WordPress
FDA Approves the checkpoint contender avelumab from Merck KGaA and Pfizer
FDA Approves the checkpoint contender avelumab from Merck KGaA and Pfizer
March 23, 2017
The biopharma partners Merck KGaA and Pfizer came away with their first FDA approval of the checkpoint inhibitor avelumab. This made it the fourth drug in this category to make it to the market. The FDA approves this for Merkel cell carcinoma under an accelerated approval process. The drug is currently in 30 clinical programs. The two pharma giants look to wedge their way into a…
View On WordPress
FDA approves first treatment Bavencio (avelumab)for rare form of skin cancer
FDA approves first treatment Bavencio (avelumab)for rare form of skin cancer
FDA approves first treatment for rare form of skin cancer 03/23/2017 The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC,…
View On WordPress
